| MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment J Bernhagen, R Krohn, H Lue, JL Gregory, A Zernecke, RR Koenen, ... Nature medicine 13 (5), 587-596, 2007 | 1485 | 2007 |
| Cytokines and atherosclerosis: a comprehensive review of studies in mice R Kleemann, S Zadelaar, T Kooistra Cardiovascular research 79 (3), 360-376, 2008 | 970 | 2008 |
| Mouse models for atherosclerosis and pharmaceutical modifiers S Zadelaar, R Kleemann, L Verschuren, J de Vries-Van der Weij, ... Arteriosclerosis, thrombosis, and vascular biology 27 (8), 1706-1721, 2007 | 710 | 2007 |
| Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. JJ Emeis, T Kooistra The Journal of experimental medicine 163 (5), 1260-1266, 1986 | 551 | 1986 |
| Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models R Kleemann, L Verschuren, M Morrison, S Zadelaar, MJ van Erk, ... Atherosclerosis 218 (1), 44-52, 2011 | 467 | 2011 |
| Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo VW Van Hinsbergh, T Kooistra, EA van den Berg, HM Princen, W Fiers, ... | 432 | 1988 |
| Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2. MC Alessi, I Juhan-Vague, T Kooistra, PJ Declerck, D Collen Thrombosis and haemostasis 60 (3), 491-494, 1988 | 399 | 1988 |
| Use of fibrinolytic agents in the prevention of postoperative adhesion formation BWJ Hellebrekers, TCM Trimbos-Kemper, JBMZ Trimbos, JJ Emeis, ... Fertility and sterility 74 (2), 203-212, 2000 | 367 | 2000 |
| Pathogenesis of postoperative adhesion formation BWJ Hellebrekers, T Kooistra British Journal of Surgery 98 (11), 1503-1516, 2011 | 326 | 2011 |
| Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells VW Van Hinsbergh, T Kooistra, MA Scheffer, J Hajo van Bockel, ... | 326 | 1990 |
| An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach GCM Bakker, MJ Van Erk, L Pellis, S Wopereis, CM Rubingh, ... The American journal of clinical nutrition 91 (4), 1044-1059, 2010 | 315 | 2010 |
| Fibrates down-regulate IL-1–stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFκB–C/EBP-β complex formation R Kleemann, PP Gervois, L Verschuren, B Staels, HMG Princen, ... Blood, The Journal of the American Society of Hematology 101 (2), 545-551, 2003 | 291 | 2003 |
| Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis R Kleemann, L Verschuren, MJ Van Erk, Y Nikolsky, NHP Cnubben, ... Genome biology 8, 1-16, 2007 | 288 | 2007 |
| Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-α activator fenofibrate P Gervois, R Kleemann, A Pilon, F Percevault, W Koenig, B Staels, ... Journal of Biological Chemistry 279 (16), 16154-16160, 2004 | 278 | 2004 |
| Plasminogen activator inhibitor 1: biosynthesis and mRNA level are increased by insulin in cultured human hepatocytes. T Kooistra, PJ Bosma, HA Töns, AP Van Den Berg, P Meyer, HM Princen Thrombosis and haemostasis 62 (2), 723-728, 1989 | 261 | 1989 |
| Evidence for anti-inflammatory activity of statins and PPARα activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro R Kleemann, L Verschuren, BJ de Rooij, J Lindeman, MM de Maat, ... Blood 103 (11), 4188-4194, 2004 | 247 | 2004 |
| Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol–lowering effect in APOE* 3-Leiden transgenic mice: evidence for … R Kleemann, HMG Princen, JJ Emeis, JW Jukema, RD Fontijn, ... Circulation 108 (11), 1368-1374, 2003 | 237 | 2003 |
| Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study JS Yudkin, I Juhan-Vague, E Hawe, SE Humphries, G di Minno, ... Metabolism 53 (7), 852-857, 2004 | 223 | 2004 |
| Human plasminogen activator inhibitor-1 gene. Promoter and structural gene nucleotide sequences. PJ Bosma, EA Van den Berg, T Kooistra, DR Siemieniak, JL Slightom Journal of Biological Chemistry 263 (19), 9129-41, 1988 | 223 | 1988 |
| Insight into the nature of the CRP–coronary event association using Mendelian randomization JP Casas, T Shah, J Cooper, E Hawe, AD McMahon, D Gaffney, ... International journal of epidemiology 35 (4), 922-931, 2006 | 209 | 2006 |
Robert KleemannTNO, Dept. Metabolic Health Research, Leiden, The NetherlandsVerified email at tno.nl